Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Return on Equity %

Nymox Pharm Corp Return on Equity % Chart (NYMX)

Nymox Pharm Corp annual/quarterly Return on Equity % from 2010 to 2020.
  • Nymox Pharm Corp Return on Equity % for the quarter ending June 06, 2020 was -6,238.73 a 97.61% decrease of -6,089.74 year over year
  • Nymox Pharm Corp Return on Equity % for the last 12 months ending June 06, 2020 was -329.27 a 16.34% decrease of -53.80 year over year
  • Nymox Pharm Corp Annual Return on Equity % for 2019 was -251.90 a -46.26% increase of 116.52 from 2018
  • Nymox Pharm Corp Annual Return on Equity % for 2018 was -368.42 a 588.61% decrease of -2,168.56 from 2017
  • Nymox Pharm Corp Annual Return on Equity % for 2017 was 1,800.13 a 43.85% increase of 789.34 from 2016
Other Margins & Efficiency Metrics:
  • Nymox Pharm Corp EBITDA Margin for the quarter ending March 03, 2015 was $63m a 263.17% increase of 166m year over year
  • Nymox Pharm Corp Return on Capital % for the quarter ending September 09, 2018 was -187.81 a -1,416.11% increase of 2,659.58 year over year
View Chart On Koyfin

Quarterly NYMX Return on Equity % Data

06/2020-6,238.73
03/2020-427.90
12/2019-236.27
09/2019-148.98
06/2019-233.10
03/2019-134.34
12/2018-199.05
09/2018-298.46
06/2018-771.92
03/2018928.63

Annual NYMX Return on Equity % Data

2019-251.90
2018-368.42
20171,800.13
20161,010.79
2015583.44
201497.34
201377.28
2012128.82
2011281.73
2010482.96